Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.945 USD | -0.88% | -3.19% | -84.12% |
May. 14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 138M |
---|---|---|---|---|---|
Net income 2024 * | -112M | Net income 2025 * | -132M | EV / Sales 2024 * | - |
Net cash position 2024 * | 152M | Net cash position 2025 * | 216M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.42
x | P/E ratio 2025 * |
-1.43
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.64% |
Latest transcript on RAPT Therapeutics, Inc.
1 day | -0.88% | ||
1 week | -3.19% | ||
Current month | -1.62% | ||
1 month | -52.64% | ||
3 months | -54.50% | ||
6 months | -76.25% | ||
Current year | -84.12% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 15-07-31 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 19-12-01 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 19-12-03 |
William Rieflin
CHM | Chairman | 64 | 15-04-30 |
Wendye Robbins
BRD | Director/Board Member | 63 | 19-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +7.26% | - | |
0.02% | 234 M€ | +8.81% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 3.94 | -1.01% | 486,918 |
24-06-03 | 3.98 | -0.75% | 889,908 |
24-05-31 | 4.01 | -0.99% | 1,038,471 |
24-05-30 | 4.05 | +2.53% | 583,549 |
24-05-29 | 3.95 | -3.07% | 595,766 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.12% | 139M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- RAPT Stock